00:05 , Nov 6, 2018 |  BC Extra  |  Company News

Management tracks: Audentes, Veloxis

Gene therapy company Audentes Therapeutics Inc. (NASDAQ:BOLD) appointed CEO and co-founder Matthew Patterson as chairman. Patterson has been a board member since 2012. Audentes also appointed board member Louis Lange as lead independent director. Lange...
18:29 , Jul 6, 2017 |  BC Week In Review  |  Financial News

Indi Molecular raises $11.5M in series A

On June 28, Indi Molecular Inc. (Culver City, Calif.) raised $11.5 million in a series A round led by M Ventures, the venture arm of Merck KGaA (Xetra:MRK). Legend Capital, Sabey Corp. (Seattle, Wash.) and...
18:29 , Jun 29, 2017 |  BC Extra  |  Financial News

Indi Molecular raises $11.5M in series A round

Indi Molecular Inc. (Culver City, Calif.) said it raised $11.5 million in a series A round led by M Ventures, the venture arm of Merck KGaA (Xetra:MRK). Also participating were Legend Capital, Sabey Corp. (Seattle,...
16:06 , Mar 16, 2017 |  BC Innovations  |  Emerging Company Profile

More needles, less haystack

Companies developing blood-based diagnostics for cancer inevitably grapple with the challenge of too little cancer-related genetic material in patient samples to make reliable diagnoses. Liquid biopsy newco Freenome Inc. is developing tests for early stage...
05:08 , Mar 3, 2017 |  BC Week In Review  |  Financial News

Freenome completes venture financing

On March 1, disease screening company Freenome Inc. (South San Francisco, Calif.) raised $65 million in a series A round led by existing investor Andreessen Horowitz. Existing investors Data Collective and Founders Fund and new...
00:02 , Mar 2, 2017 |  BC Extra  |  Financial News

Freenome raises $65M in series A

Disease screening company Freenome Inc. (South San Francisco, Calif.) said it raised $65 million in a series A round led by existing investor Andreessen Horowitz. Prior investors Data Collective and Founders Fund also participated, as...
01:45 , May 6, 2016 |  BC Extra  |  Financial News

ViewPoint raises $4M in series A

ViewPoint Therapeutics Inc. (San Francisco, Calif.) raised $4 million in a series A round co-led by Mission Bay Capital and Lagunita BioSciences. Biotechnology Value Fund, the University of Michigan MINTS initiative, Asset Management Ventures and...
07:00 , May 7, 2015 |  BC Innovations  |  Emerging Company Profile

Twist Bioscience Corp. Corporate Profile

Twist Bioscience Corp. San Francisco, Calif. Technology: Silicon-based DNA synthesis platform Disease focus: Supply/Service Clinical status: Marketed Founded: 2013 by Emily Leproust, Bill Banyai and Bill Peck University collaborators: None Corporate partners: None Number of...
07:00 , Aug 11, 2014 |  BioCentury  |  Product Development

Internalizing outcomes

Proteus Digital Health Inc. hopes its Helius computer-enabled ingestible sensor system can deliver real-time monitoring of oral medication outcomes. The company's challenges are to convince payers that the added cost of the system is justified...
07:00 , Mar 31, 2014 |  BioCentury  |  Emerging Company Profile

Indi Molecular: Building better binders

Indi Molecular Inc. 's protein-catalyzed capture platform produces synthetic peptides that could be used as in vivo imaging agents and in vitro diagnostics when low target immunogenicity or suboptimal pharmacokinetics limit the utility of mAbs....